Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Jun 1, 2012Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
8-A12G/AAmendment to a previously filed 8-A12GMay 30, 2012Open Amendment to a previously filed 8-A12G in HTML.Open Amendment to a previously filed 8-A12G in DOC file.Open Amendment to a previously filed 8-A12G in PDF file.Open Amendment to a previously filed 8-A12G in XLS file.
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3May 30, 2012Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in HTML.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in DOC file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in PDF file.Open Form of prospectus disclosing information facts events covered in both forms 424B2 424B3 in XLS file.
S-8 POSPost-effective amendment to an S-8 filingMay 29, 2012Open Post-effective amendment to an S-8 filing in HTML.Open Post-effective amendment to an S-8 filing in DOC file.Open Post-effective amendment to an S-8 filing in PDF file.Open Post-effective amendment to an S-8 filing in XLS file.
S-8Securities offered to employees pursuant to employee benefit plansMay 25, 2012Open Securities offered to employees pursuant to employee benefit plans in HTML.Open Securities offered to employees pursuant to employee benefit plans in DOC file.Open Securities offered to employees pursuant to employee benefit plans in PDF file.Open Securities offered to employees pursuant to employee benefit plans in XLS file.

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq®
Brineura®
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information